Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurent Deferred Tax LiabilityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Amdocs (DOX) over the last 17 years, with Q3 2025 value amounting to $325.0 million.

  • Amdocs' Cash & Equivalents fell 609.27% to $325.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $325.0 million, marking a year-over-year decrease of 609.27%. This contributed to the annual value of $325.0 million for FY2025, which is 609.27% down from last year.
  • Amdocs' Cash & Equivalents amounted to $325.0 million in Q3 2025, which was down 609.27% from $346.1 million recorded in Q2 2025.
  • In the past 5 years, Amdocs' Cash & Equivalents registered a high of $969.0 million during Q1 2021, and its lowest value of $213.8 million during Q4 2024.
  • Its 5-year average for Cash & Equivalents is $541.0 million, with a median of $520.1 million in 2023.
  • As far as peak fluctuations go, Amdocs' Cash & Equivalents skyrocketed by 2706.34% in 2021, and later crashed by 4415.22% in 2024.
  • Over the past 5 years, Amdocs' Cash & Equivalents (Quarter) stood at $709.1 million in 2021, then plummeted by 30.59% to $492.2 million in 2022, then fell by 22.21% to $382.9 million in 2023, then tumbled by 44.15% to $213.8 million in 2024, then skyrocketed by 51.99% to $325.0 million in 2025.
  • Its Cash & Equivalents was $325.0 million in Q3 2025, compared to $346.1 million in Q2 2025 and $346.1 million in Q1 2025.